COVID-19

Alcohol-based hand sanitizers do not protect against norovirus, a highly contagious virus. Effective alternatives like hypochlorous acid-based sanitizers are crucial for better infection control.

Hadassah Medical Organization's pooled saliva testing for newborns effectively screens for congenital cytomegalovirus, identifying asymptomatic cases and potentially reducing severe cognitive and auditory problems globally.

Setting boundaries becomes crucial as health care workers face rising demands and burnout. Learn practical strategies to protect mental well-being and prevent burnout in the workplace.

Health care has an unmet need for the treatment of herpesviruses, hepatitis B, and hepatitis D, which would enhance patient outcomes. What should be done, and what challenges do companies that are trying to develop treatments face?

Opinion: Kevin Kavanagh, MD, examines a summary of studies on how COVID-19 may damage the brain's frontal lobes, alter personality traits and cognitive functions, and potentially reshape society's dynamics.

Amid escalating multidrug-resistant organism threats, hospitals face business risks and patient trust erosion, necessitating improved cleaning and infection prevention practices.

The role of infection preventionists (IPs) has evolved significantly over 75 years, from early surveillance of nosocomial infections to becoming data-driven experts navigating pandemics like COVID-19.

Media in the US presents AI as both beneficial and risky. Positive coverage shows AI's potential through virtual assistants like Siri, while cautionary tales warn of misuse like misinformation and deepfakes. How does all this work in health care?

Anne Meneghetti, MD, highlights the misconceptions that drive individuals to seek antibiotics for common colds sooner than necessary.

In the ongoing fight against COVID-19, the FDA has granted Emergency Use Authorization for Pemgarda, a COVID-19 infusion drug. Read on for more.

Four years ago today, March 15, 2020, the COVID-19 lockdown began, and since then, the world has undergone significant changes. It has been a terrifying experience for everyone, especially for the infection prevention community, both within and outside of the health care sector. However, a crucial question remains unanswered: What has the infection prevention community learned from this pandemic, and where does it go from here?

The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.

Meet the experts shaping infection prevention: Infection Control Today's Editorial Board members share insights, experiences, and cutting-edge strategies to enhance health care safety and quality. Meet Tabrikah Mohammed, MSc, BSN, CIC, CPHQ, FAPIC.

Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.

A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.

Despite the severity of a measles diagnosis, outbreaks continue. Health care workers should encourage their patients to receive the vaccine and explain its safety.

The journey of pregnancy begins long before conception, with a woman's lifestyle choices profoundly influencing her future child's health. From diet to infection prevention, proactive measures are crucial.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending February 17, 2024.

VR training is a game-changer in PPE skills for health care amidst COVID-19. Study shows superiority over traditional methods, revolutionizing safety education, according to a study published today.

Stephanie Alice Baker, PhD, delves into the surge of antivaccine influencers during COVID-19, highlighting their impact on vaccine hesitancy and misinformation.

Learn about FendX Technologies' breakthrough nanotechnology, including REPELWRAP film and a spray formulation, designed to prevent the spread of infectious diseases on various surfaces.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending February 4, 2024.

CSL achieves a global milestone as Japan approves ARCT-154, the first sa-mRNA COVID-19 vaccine, showcasing CSL's commitment to innovation, efficacy, and prolonged protection against variants. Jonathan Edelman, MD, senior VP of CSL Vaccine’s Innovation Unit, speaks with ICT.

Frontline infection preventionists (IPs) face burnout due to challenges in public health. This Round Table on IP Burnout discusses strategies to prevent and address this critical issue. The IPs emphasize the importance of understanding burnout, recognizing signs, addressing stigma, and implementing multilayered prevention strategies for both individuals and organizations.

FDA guides the transition from emergency-use-labeled Paxlovid to approved labeling, impacting dispensing sites, providers, and patients.